Eton Pharmaceuticals Ownership | Who Owns Eton Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Eton Pharmaceuticals Ownership Summary


Eton Pharmaceuticals is owned by 64.90% institutional investors, 4.39% insiders, and 30.71% retail investors. Opaleye management is the largest institutional shareholder, holding 10.63% of ETON shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.56% of its assets in Eton Pharmaceuticals shares.

ETON Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEton Pharmaceuticals64.90%4.39%30.71%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Opaleye management2.86M10.63%$62.15M
Ecor1 capital2.03M7.55%$44.12M
Blackrock funding, inc. /de1.70M6.34%$37.04M
Vanguard group1.34M5.00%$29.21M
Nantahala capital management1.18M4.37%$25.55M
Morgan stanley586.05K2.18%$12.73M
Geode capital management574.03K2.13%$12.48M
Royal bank of canada479.19K1.78%$10.41M
Westside investment management472.54K1.76%$10.27M
Cannell capital455.40K1.69%$9.90M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Opaleye management2.86M8.79%$62.15M
Ecor1 capital2.03M2.12%$44.12M
Westside investment management472.54K1.64%$10.27M
Cannell capital455.40K1.51%$9.90M
Lumbard & kellner176.30K1.41%$3.83M
Nantahala capital management1.18M0.89%$25.55M
Diametric capital, lp99.31K0.80%$2.16M
Apis capital advisors117.60K0.56%$2.56M
Aristides capital167.59K0.53%$3.64M
Divisadero street capital management, lp298.00K0.28%$6.48M

Top Buyers

HolderShares% AssetsChange
Royal bank of canada479.19K0.00%474.13K
Oberweis asset management inc/192.36K0.16%192.36K
Lumbard & kellner176.30K1.41%176.30K
Blackrock funding, inc. /de1.70M0.00%172.65K
Bnp paribas arbitrage, snc229.79K0.00%142.09K

Top Sellers

HolderShares% AssetsChange
Acadian asset management26.41K0.00%-366.31K
Parkman healthcare partners---276.89K
Wasatch advisors lp---231.33K
Paradigm capital management inc/ny---200.00K
Divisadero street capital management, lp298.00K0.28%-199.72K

New Positions

HolderShares% AssetsChangeValue
Oberweis asset management inc/192.36K0.16%192.36K$4.18M
Lumbard & kellner176.30K1.41%176.30K$3.83M
Millennium management138.89K0.00%138.89K$1.85M
Winton group35.30K0.03%35.30K$767.16K
Calamos advisors23.63K0.00%23.63K$513.57K

Sold Out

HolderChange
Lindbrook capital-4.00
Federated hermes-686.00
Plante moran financial advisors-1.00K
Lazard asset management-1.03K
Adar1 capital management-1.20K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20259818.07%17,454,5999.66%641.85%51-12.07%2758.82%
Jun 30, 202586-1.15%16,537,10735.73%612.99%6115.09%17-26.09%
Mar 31, 20258920.27%14,123,1147.52%522.04%531.92%2471.43%
Dec 31, 202424-52.94%3,267,082-65.64%120.94%14-46.15%6-
Sep 30, 2024518.51%9,507,91415.55%363.60%2685.71%6-60.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv686.28K2.56%-15.23K
Vanguard US Total Market Shares ETF681.72K2.54%-
iShares Russell 2000 ETF625.31K2.33%-
Vanguard Institutional Extnd Mkt Idx Tr275.36K1.03%-119.33K
Fidelity Small Cap Index256.87K0.96%256.87K
iShares Russell 2000 Growth ETF222.68K0.83%-
Paradigm Micro-Cap200.00K0.77%-
Fidelity Extended Market Index137.49K0.51%-1.13K
Vanguard Russell 2000 ETF122.35K0.46%-8.18K
Wasatch Micro Cap Value105.10K0.40%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 20, 2025Gruber James R. Chief Financial OfficerSell$42.15K
Aug 19, 2025Gruber James R. Chief Financial OfficerSell$631.57K
Jun 12, 2025Krempa David Chief Business OfficerSell$253.30K
Jun 13, 2025Krempa David Chief Business OfficerSell$100.44K
Jun 16, 2025Krempa David Chief Business OfficerSell$150.58K

Insider Transactions Trends


DateBuySell
2025 Q3-2
2025 Q228
2025 Q1--
2024 Q47-
2024 Q34-

ETON Ownership FAQ


Who Owns Eton Pharmaceuticals?

Eton Pharmaceuticals shareholders are primarily institutional investors at 64.90%, followed by 4.39% insiders and 30.71% retail investors. The average institutional ownership in Eton Pharmaceuticals's industry, Biotech Stocks , is 45.22%, which Eton Pharmaceuticals exceeds.

Who owns the most shares of Eton Pharmaceuticals?

Eton Pharmaceuticals’s largest shareholders are Opaleye management (2.86M shares, 10.63%), Ecor1 capital (2.03M shares, 7.55%), and Blackrock funding, inc. /de (1.7M shares, 6.34%). Together, they hold 24.52% of Eton Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eton Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Eton Pharmaceuticals.

Who is Eton Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Opaleye management is Eton Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 8.79% of its assets in 2.86M Eton Pharmaceuticals shares, valued at 62.15M$.

Who is the top mutual fund holder of Eton Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eton Pharmaceuticals shares, with 2.56% of its total shares outstanding invested in 686.28K Eton Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools